Extraction and Analysis of a Definitive Drug Panel in Hair Samples by UHPLC-MS/MS for Forensic Toxicology

Importance of the Topic

Hair provides a unique biological matrix for forensic toxicology, offering a non-invasive collection, ease of transport and storage, and an extended detection window spanning months. Its incorporation mechanisms and stability make it invaluable for confirming long-term drug exposure in contexts such as post-mortem investigations, drug-facilitated crimes, and employment monitoring.

Objectives and Study Overview

This study aimed to develop and validate a comprehensive UHPLC-MS/MS method for quantifying a broad panel of drugs of abuse in hair, in line with Society of Hair Testing cut-off criteria. The target analytes included natural and synthetic opiates, stimulants, benzodiazepines, fentanyls, and other common controlled substances.

Methodology and Instrumentation

Sample preparation combined sequential solvent decontamination, mechanical pulverization, and high-temperature incubation to maximize extraction efficiency across diverse chemistries. Cleanup was conducted on mixed-mode cation exchange (Oasis MCX) 96-well plates. Chromatographic separation employed an ACQUITY UPLC I-Class Plus System with a BEH C18 column (2.1×100 mm, 1.7 µm) under a water/acetonitrile gradient containing formic acid. Detection utilized a Xevo TQ Absolute Triple Quadrupole Mass Spectrometer operating in positive ESI with optimized MRM transitions. Quantification and data processing were handled by MassLynx and TargetLynx software.

Instrumentation

• Precellys Tissue Homogenizer with CKMix Lysing Kits
• Waters ACQUITY UPLC I-Class Plus System
• ACQUITY UPLC BEH C18 Column (1.7 µm, 2.1×100 mm)
• Waters Xevo TQ Absolute Triple Quadrupole MS
• Oasis MCX 96-well SPE plates
• MassLynx and TargetLynx data systems

Main Results and Discussion

Chromatography achieved baseline separation of all compounds within 3.2 minutes and a total cycle time of 4.0 minutes. Average recoveries were 58%, with 49 of 58 analytes above 40%, and matrix effects averaged 20%, mitigated by deuterated internal standards. Calibration curves were linear (R2 ≥0.99) over 0.01–1.0 ng/mg (lower ranges for fentanyl and metabolites). Accuracy and precision met acceptance criteria (±15%, CV <15%) except for phentermine and metadesnitazine. Limits of quantification satisfied Society of Hair Testing requirements for all but phentermine. External quality control samples demonstrated excellent agreement, with over 80% of analytes within defined acceptance windows.

Benefits and Practical Applications

• Extended detection window for retrospective drug use profiling
• Non-invasive and easily supervised sample collection
• High throughput workflow with 96-well format SPE
• Rapid UHPLC separation coupled to sensitive MS quantification
• Compliance with international forensic cut-off guidelines

Future Trends and Potential Applications

Advances may include integration of high-resolution and non-target screening for unknown metabolites, automated sample preparation platforms, miniaturized and portable LC-MS systems for field testing, and expanded panels covering emerging synthetic drugs and novel biomarkers of drug use.

Conclusion

The optimized UHPLC-MS/MS method offers a robust, sensitive, and rapid solution for multi-analyte drug testing in hair, fulfilling forensic cut-off requirements and demonstrating reliable performance across recovery, matrix effect, accuracy, and precision metrics. Its implementation can enhance long-term drug monitoring in forensic and clinical settings.

References

• Cooper GA, Kronstrand R, Kintz P. Society of Hair Testing Guidelines for Drug Testing in Hair. Forensic Science International. 2012;281:20–24.
• Society of Hair Testing. Statements of the Society of Hair Testing Concerning the Examination of Drugs in Human Hair. 2024.
• Hu J, Chen H, et al. Pulverization is a crucial step – A Comparative Study of Different Pretreatments in Hair Drug Testing. Journal of Analytical Toxicology. 2023;47:346–352.